Furthermore, overexpression of MMP-9 and MMP-2 was identified in the HCC-induced groups, which is consistent with Chang et al’s findings that DEN therapy elevated MMP-9 and MMP-2 levels as compared to the control group [82]. This evidence concerns the gene MMP2 and hepatocellular carcinoma.